OR WAIT null SECS
There are positive indications for future growth.
Revolutionary therapies restructure pharmaceutical manufacturing.
Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.
February 27, 2024
CSL will share access to Cytegrity, its proprietary stable production system for lentiviral vector production, with Genezen.
February 22, 2024
Daiichi Sankyo is investing approximately €1 billiion (US$1.08 billion) to expand its Pfaffenhofen an der Ilm, Germany, site for ADC development and production.
February 21, 2024
AstraZeneca has completed its acquisition of Icosavax, gaining the IVX-A12 vaccine candidate that targets RSV and hMPV.
Webinar Date/Time: Wed, Mar 20, 2024 11:00 AM EDT
February 20, 2024
Challenges in fermentation can be addressed through equipment changes, facility design, and process development.
FDA has approved Iovance Biotherapeutics’ Amtagvi (lifileucel) for treating patients with unresectable or metastatic melanoma.
February 12, 2024
Under the new partnership, Samsung Biologics will develop and manufacture an antibody for a LegoChem Biosciences ADC candidate.
Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST
February 07, 2024
Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.
February 05, 2024
Novo Holdings has entered into a merger agreement with Catalent and will acquire Catalent in a deal valued at $16.5 billion.